G101S (p.Gly101Ser) variant of SMARCE1 (Q969G3)

G101S (p.Gly101Ser) in SMARCE1 (Q969G3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Familial meningioma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.93 / 1. The record also includes published literature and structural context.

G101S (p.Gly101Ser) variant details